Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Alopecia universalis, Parakeratosis, Perioral hyperkeratosis, and Flexion contracture of digit and others; and common findings: Woolly hair.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 6 | Alopecia universalis, Perioral hyperkeratosis, Pruritus |
PERP function has not been fully characterized.
Olmsted syndrome 2 is associated with mutations in the PERP gene on chromosome 6.
Genetic testing for PERP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Olmsted syndrome 2 has been reported in the published literature.
Phenotype severity distribution: 11 always present features, 1 common feature.
No clinical trials have been registered for Olmsted syndrome 2.
12 publications have been identified in PubMed for Olmsted syndrome 2. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:48 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Olmsted syndrome 2
1 |
Flexion contracture of digit |
Arms and legs | 1 | Flexion contracture of digit |
3 |
25% |
Disease patterns and progression | 2 | 17% |
Testing and diagnosis research | 1 | 8% |
Research summaries | 1 | 8% |
New treatment approaches | 1 | 8% |
Holloway A (2026). [PMID: 41787805](https://pubmed.ncbi.nlm.nih.gov/41787805/). *Biophys J*. [Basic Science / Preclinical]
Neblett MF 2nd (2026). [PMID: 41288454](https://pubmed.ncbi.nlm.nih.gov/41288454/). *Menopause*. [Epidemiology / Natural History]
Azulay-Abulafia L (2026). [PMID: 41895212](https://pubmed.ncbi.nlm.nih.gov/41895212/). *An Bras Dermatol*. [Case Report / Case Series]
Chattapadhya A (2026). [PMID: 41932384](https://pubmed.ncbi.nlm.nih.gov/41932384/). *Life Sci*. [Basic Science / Preclinical]
Jiang X (2025). [PMID: 40758889](https://pubmed.ncbi.nlm.nih.gov/40758889/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Diversi F (2025). [PMID: 40171279](https://pubmed.ncbi.nlm.nih.gov/40171279/). *Mol Ther Nucleic Acids*. [Gene Therapy / Novel Therapeutics]
Lu A (2024). [PMID: 39748945](https://pubmed.ncbi.nlm.nih.gov/39748945/). *Front Genet*. [Review / Meta-Analysis]
Vaughan LE (2024). [PMID: 39503653](https://pubmed.ncbi.nlm.nih.gov/39503653/). *J Am Coll Cardiol*. [Epidemiology / Natural History]
Hamidi O (2024). [PMID: 38941271](https://pubmed.ncbi.nlm.nih.gov/38941271/). *Eur J Endocrinol*. [Diagnostic / Biomarker]
Pandapatan AT (2024). [PMID: 39431258](https://pubmed.ncbi.nlm.nih.gov/39431258/). *Acta Med Philipp*. [Case Report / Case Series]